Reuters Events and GRAIL present: ‘Multi-Cancer Early Detection for Health Systems: Four Adoption Models’
The American Cancer Society estimated that over 600,000 will have died from cancer by the end of 2022, averaging over 1,600 deaths a day as a result of cancer.
As the second leading cause of death in the US, and costs of treatment spiralling out of control for later-stage cancers, we must implement sustainable screening technologies which help our nation’s providers and patients in detecting cancer
Discover exclusive insights from leading health systems such as Providence, HCA Healthcare and Ochsner around how to implement a successful cancer screening program, using early detection technologies to address social determinants of health and advance health equity as well as more.
Key takeaways include how to:
- Healthcare’s opportunity: Bring early-stage intervention and prevention to primary care with the help of Multi-Cancer Early Detection (MCED) technologies
- Breaking boundaries: Successfully deploy MCED technologies within your health system and learn how stakeholders must collaborate to make this happen
- Forward-thinking: Set the roadmap for a successful value-based care strategy within your health organization as a result of cutting-edge cancer screening strategies
Contributors include
Join Reuters Events in forging a sustainable future for cancer early detection!
Kind regards,
Natalie Diaz-Martin
Global Project Director
Healthcare
Reuters Events
Telephone: +44 20 3197 8105
Reuters Events is part of Reuters News & Media Ltd, 5 Canada Square, Canary Wharf, London, E14 5AQ. Registered in England and Wales: 2505735.